Odyssey Therapeutics is a biotechnology company that offers innovative drug discovery and development solutions for patients with inflammatory diseases and cancer.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
11/21/2024 | Series C-1 | $25MM | $xx.xx | $714.3MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,865,327
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/05/2023 | Series C | $117.21MM | $xx.xx | $619.46MM | Ab Magnitude Ventures, Alexandria Venture Investments, Ascenta Capital, Blackmars Capital Gmbh, Catalio Capital Management, Colt Ventures, Creacion Ventures, Fidelity, Foresite Capital, General Catalyst, Hbm Healthcare Investments, Kb Investment, Leerink Partners, Orbimed, Racing Beach Ventures Llc, Sr One Capital Management, The Global Bioaccess Fund, The Healthcare Innovation Investment Fund Llc, T. Rowe Price Associates, Walleye Capital, Woodline Partners | |
Price per Share
$xx.xx
Shares Outstanding
23,442,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ab Magnitude Ventures, Alexandria Venture Investments, Ascenta Capital, Blackmars Capital Gmbh, Catalio Capital Management, Colt Ventures, Creacion Ventures, Fidelity, Foresite Capital, General Catalyst, Hbm Healthcare Investments, Kb Investment, Leerink Partners, Orbimed, Racing Beach Ventures Llc, Sr One Capital Management, The Global Bioaccess Fund, The Healthcare Innovation Investment Fund Llc, T. Rowe Price Associates, Walleye Capital, Woodline Partners
|
||||||
10/13/2022 | Series B | $168.01MM | $xx.xx | $616.51MM | Alexandria Venture Investments, Catalio Capital Management, Colt Ventures, Creacion Ventures, Fidelity, Foresite Capital, General Catalyst, Greatpoint Ventures, Hbm Healthcare Investments, Logos Capital, Orbimed, Sr One Capital Management, The Healthcare Innovation Investment Fund Llc, T. Rowe Price Associates, Walleye Capital, Woodline Partners | |
Price per Share
$xx.xx
Shares Outstanding
26,601,360
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alexandria Venture Investments, Catalio Capital Management, Colt Ventures, Creacion Ventures, Fidelity, Foresite Capital, General Catalyst, Greatpoint Ventures, Hbm Healthcare Investments, Logos Capital, Orbimed, Sr One Capital Management, The Healthcare Innovation Investment Fund Llc, T. Rowe Price Associates, Walleye Capital, Woodline Partners
|
||||||
12/07/2021 | Series A | $130.43MM | $xx.xx | $390.8MM | Colt Ventures, Creacion Ventures, Foresite Capital, Hbm Healthcare Investments, Logos Capital, Orbimed, Sr One Capital Management, Woodline Partners | |
Price per Share
$xx.xx
Shares Outstanding
30,039,874
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Colt Ventures, Creacion Ventures, Foresite Capital, Hbm Healthcare Investments, Logos Capital, Orbimed, Sr One Capital Management, Woodline Partners
|
||||||
12/07/2021 | Series A-1 | $44.41MM | $xx.xx | $390.8MM | Colt Ventures, Creacion Ventures, Foresite Capital, Hbm Healthcare Investments, Logos Capital, Orbimed, Sr One Capital Management, Woodline Partners | |
Price per Share
$xx.xx
Shares Outstanding
7,575,753
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Colt Ventures, Creacion Ventures, Foresite Capital, Hbm Healthcare Investments, Logos Capital, Orbimed, Sr One Capital Management, Woodline Partners
|
||||||
12/07/2021 | Series A-2 | $48.1MM | $xx.xx | $390.8MM | Colt Ventures, Creacion Ventures, Foresite Capital, Hbm Healthcare Investments, Logos Capital, Orbimed, Sr One Capital Management, Woodline Partners | |
Price per Share
$xx.xx
Shares Outstanding
7,815,303
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Colt Ventures, Creacion Ventures, Foresite Capital, Hbm Healthcare Investments, Logos Capital, Orbimed, Sr One Capital Management, Woodline Partners
|